BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Richards KE, Xiao W, Hill R, On Behalf Of The Usc Pancreas Research Team. Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes. Cancers (Basel) 2022;14:2812. [PMID: 35681792 DOI: 10.3390/cancers14112812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Naito Y, Yoshioka Y, Ochiya T. Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via extracellular vesicles. Cancer Cell Int 2022;22:367. [PMID: 36424598 DOI: 10.1186/s12935-022-02784-8] [Reference Citation Analysis]
2 Chiangjong W, Chutipongtanate S. EV-out or EV-in: Tackling cell-to-cell communication within the tumor microenvironment to enhance anti-tumor efficacy using extracellular vesicle-based therapeutic strategies. OpenNano 2022;8:100085. [DOI: 10.1016/j.onano.2022.100085] [Reference Citation Analysis]
3 Zhang W, Campbell DH, Walsh BJ, Packer NH, Liu D, Wang Y. Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. J Nanobiotechnology 2022;20:446. [PMID: 36242076 DOI: 10.1186/s12951-022-01641-0] [Reference Citation Analysis]
4 Wang H, Min J, Liu J, Xu C, Liu Y, Yu Z, Gong A, Xu M. Hypoxia-elicited exosomes promote the chemoresistance of pancreatic cancer cells by transferring lncROR via Hippo signaling.. [DOI: 10.21203/rs.3.rs-2092052/v1] [Reference Citation Analysis]